{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:24:26Z","timestamp":1790771066823,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T00:00:00Z","timestamp":1642464000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007497","name":"Biosense Webster","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.cjca.2022.01.016","type":"journal-article","created":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T02:09:39Z","timestamp":1642730979000},"page":"454-464","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Ventricular Tachycardia Burden and Mortality: Association or Causality?"],"prefix":"10.1016","volume":"38","author":[{"given":"Michelle","family":"Samuel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ihab","family":"Elsokkari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9602-2751","authenticated-orcid":false,"given":"John L.","family":"Sapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2022.01.016_bib1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.gheart.2018.09.511","article-title":"Global Atlas of Cardiovascular Disease 2000-2016: the path to prevention and control","volume":"13","author":"Thomas","year":"2018","journal-title":"Glob Heart"},{"key":"10.1016\/j.cjca.2022.01.016_bib2","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.jacc.2011.01.049","article-title":"Sudden death in young adults: an autopsy-based series of a population undergoing active surveillance","volume":"58","author":"Eckart","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2022.01.016_bib3","first-page":"822","article-title":"2020 Canadian Cardiovascular Society\/Canadian Heart Rhythm Society position statement on the management of ventricular tachycardia and fibrillation in patients with structural heart disease","volume":"36","author":"Deyell","year":"2020","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2022.01.016_bib4","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.jacc.2017.10.054","volume":"72","author":"Al-Khatib","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2022.01.016_bib5","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","volume":"36","author":"Priori","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2022.01.016_bib6","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1161\/CIRCULATIONAHA.110.940148","article-title":"Long-term benefit of primary prevention with an implantable cardioverter-defibrillator: an extended 8-year follow-up study of the Multicenter Automatic Defibrillator Implantation Trial II","volume":"122","author":"Goldenberg","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2022.01.016_bib7","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1161\/01.CIR.101.11.1297","article-title":"Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone","volume":"101","author":"Connolly","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2022.01.016_bib8","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1053\/euhj.2000.2476","article-title":"Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study","volume":"21","author":"Connolly","year":"2000","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2022.01.016_bib9","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJM199711273372202","article-title":"A\u00a0comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias","volume":"337","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2022.01.016_bib10","doi-asserted-by":"crossref","first-page":"445","DOI":"10.7326\/0003-4819-138-6-200303180-00007","article-title":"Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials","volume":"138","author":"Ezekowitz","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cjca.2022.01.016_bib11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.295.2.165","article-title":"Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial","volume":"295","author":"Connolly","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2022.01.016_bib12","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1161\/hc0502.103330","article-title":"Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks","volume":"105","author":"Schron","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2022.01.016_bib13","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1046\/j.1540-8167.2003.01554.x","article-title":"Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial","volume":"14","author":"Klein","year":"2003","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.cjca.2022.01.016_bib14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2022.01.016_bib15","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1161\/01.CIR.103.16.2066","article-title":"Electrical storm presages nonsudden death: the antiarrhythmics versus implantable defibrillators (AVID) trial","volume":"103","author":"Exner","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2022.01.016_bib16","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1046\/j.1540-8167.2004.04352.x","article-title":"Prevalence, predictors, and mortality significance of the causative arrhythmia in patients with electrical storm","volume":"15","author":"Verma","year":"2004","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.cjca.2022.01.016_bib17","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1161\/01.CIR.93.4.753","article-title":"Incidence and clinical significance of multiple consecutive, appropriate, high-energy discharges in patients with implanted cardioverter-defibrillators","volume":"93","author":"Villacastin","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2022.01.016_bib18","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jacc.2009.06.003","article-title":"Predicting outcome after implantable cardioverter-defibrillator therapy: a new piece to the puzzle?","volume":"54","author":"Shepard","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2022.01.016_bib19","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1016\/j.hrthm.2016.05.017","article-title":"Mechanisms linking electrical alternans and clinical ventricular arrhythmia in human heart failure","volume":"13","author":"Bayer","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2022.01.016_bib20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.amjcard.2017.04.020","article-title":"Meta-analysis of risk of ventricular arrhythmias after improvement in left ventricular ejection fraction during follow-up in patients with primary prevention implantable cardioverter defibrillators","volume":"120","author":"Smer","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2022.01.016_bib21","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.hrthm.2009.11.027","article-title":"Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients","volume":"7","author":"Sweeney","year":"2010","journal-title":"Heart Rhythm"},{"issue":"suppl 2","key":"10.1016\/j.cjca.2022.01.016_bib22","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.eupc.2005.04.011","article-title":"Electroporation of the heart","volume":"7","author":"Nikolski","year":"2005","journal-title":"Europace"},{"key":"10.1016\/j.cjca.2022.01.016_bib23","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0735-1097(99)00194-1","article-title":"Detection of myocardial injury during transvenous implantation of automatic cardioverter-defibrillators","volume":"34","author":"Hurst","year":"1999","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2022.01.016_bib24","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0002-9149(97)00090-8","article-title":"Myocardial injury after electrical therapy for cardiac arrhythmias assessed by troponin-T release","volume":"79","author":"Runsio","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2022.01.016_bib25","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1540-8167.1998.tb00118.x","article-title":"Effect of ventricular shock strength on cardiac hemodynamics","volume":"9","author":"Tokano","year":"1998","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.cjca.2022.01.016_bib26","series-title":"Causal Inference: What If","author":"Hern\u00e1n","year":"2020"},{"key":"10.1016\/j.cjca.2022.01.016_bib27","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/EDE.0b013e3181875e61","article-title":"Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease","volume":"19","author":"Hern\u00e1n","year":"2008","journal-title":"Epidemiology"},{"key":"10.1016\/j.cjca.2022.01.016_bib28","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/aje\/kwv254","article-title":"Using big data to emulate a target trial when a randomized trial is not available","volume":"183","author":"Hernan","year":"2016","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.cjca.2022.01.016_bib29","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1136\/jech.2004.029496","article-title":"Estimating causal effects from epidemiological data","volume":"60","author":"Hern\u00e1n","year":"2006","journal-title":"J\u00a0Epidemiol Community Health"},{"key":"10.1016\/j.cjca.2022.01.016_bib30","first-page":"1365","article-title":"Emulating a randomised controlled trial with observational data: an introduction to the target trial framework","volume":"37","author":"Kutcher","year":"2021","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2022.01.016_bib31","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1016\/j.jacc.2019.03.484","article-title":"Statistical appraisal of 6 recent clinical trials in cardiology: JACC State-of-the-Art Review","volume":"73","author":"Pocock","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2022.01.016_bib32","series-title":"Statistical Models in Epidemiology, the Environment, and Clinical Trials. The IMA Volumes in Mathematics and its Applications","article-title":"Marginal structural models versus structural nested models as tools for causal inference","volume":"116","author":"Robins","year":"2000"},{"key":"10.1016\/j.cjca.2022.01.016_bib33","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/EDE.0000000000000053","article-title":"Constructing inverse probability weights for continuous exposures: a comparison of methods","volume":"25","author":"Naimi","year":"2014","journal-title":"Epidemiology"},{"key":"10.1016\/j.cjca.2022.01.016_bib34","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/S0735-1097(98)00495-1","article-title":"Electrical storm in patients with transvenous implantable cardioverter-defibrillators: incidence, management and prognostic implications","volume":"32","author":"Credner","year":"1998","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2022.01.016_bib35","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJMoa071098","article-title":"Prognostic importance of defibrillator shocks in patients with heart failure","volume":"359","author":"Poole","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2022.01.016_bib36","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.hrthm.2016.03.022","article-title":"Extended detection time to reduce shocks is safe in secondary prevention patients: the secondary prevention substudy of PainFree SST","volume":"13","author":"Sterns","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2022.01.016_bib37","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1161\/01.CIR.0000145610.64014.E4","volume":"110","author":"Wathen","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2022.01.016_bib38","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jacc.2008.05.011","article-title":"Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study","volume":"52","author":"Wilkoff","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2022.01.016_bib39","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jacc.2006.03.037","article-title":"A\u00a0comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: results from the prospective randomized multicenter EMPIRIC trial","volume":"48","author":"Wilkoff","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2022.01.016_bib40","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.hrthm.2011.07.036","article-title":"Shocks burden and increased mortality in implantable cardioverter-defibrillator patients","volume":"8","author":"Larsen","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2022.01.016_bib41","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cjco.2019.04.003","article-title":"The effect of shock burden on heart failure and mortality","volume":"1","author":"MacIntyre","year":"2019","journal-title":"CJC Open"},{"key":"10.1016\/j.cjca.2022.01.016_bib42","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.hrthm.2020.12.034","article-title":"Cardiac resynchronization therapy and ventricular tachyarrhythmia burden","volume":"18","author":"Tankut","year":"2021","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2022.01.016_bib43","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJMoa0906431","article-title":"Cardiac-resynchronization therapy for the prevention of heart-failure events","volume":"361","author":"Moss","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2022.01.016_bib44","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1016\/j.jacc.2021.03.329","article-title":"Survival after implantable cardioverter-defibrillator shocks","volume":"77","author":"Aktas","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2022.01.016_bib45","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199507133330201","article-title":"Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure","volume":"333","author":"Singh","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2022.01.016_bib46","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1056\/NEJMoa1211107","article-title":"Reduction in inappropriate therapy and mortality through ICD programming","volume":"367","author":"Moss","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2022.01.016_bib47","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jacc.2018.04.086","article-title":"Ranolazine in high-risk patients with implanted cardioverter-defibrillators: the RAID trial","volume":"72","author":"Zareba","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2022.01.016_bib48","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jacep.2019.11.012","article-title":"Mortality risk increases with clustered ventricular arrhythmias in patients with implantable cardioverter-defibrillators","volume":"6","author":"Elsokkari","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.cjca.2022.01.016_bib49","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.hrthm.2015.10.022","article-title":"Ventricular antitachycardia pacing therapy in patients with heart failure implanted with a cardiac resynchronization therapy defibrillator device: efficacy, safety, and impact on mortality","volume":"13","author":"Landolina","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2022.01.016_bib50","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1111\/jce.14688","article-title":"Characteristics of ventricular tachyarrhythmias and their susceptibility to antitachycardia pacing termination in patients with ischemic and nonischemic cardiomyopathy: a patient-level meta-analysis of three large clinical trials","volume":"31","author":"Cheng","year":"2020","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.cjca.2022.01.016_bib51","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1513614","article-title":"Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs","volume":"375","author":"Sapp","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2022.01.016_bib52","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(09)61755-4","article-title":"Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial","volume":"375","author":"Kuck","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2022.01.016_bib53","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1161\/CIRCULATIONAHA.119.043400","article-title":"Preventive or deferred ablation of ventricular tachycardia in patients with ischemic cardiomyopathy and implantable defibrillator (BERLIN VT): a multicenter randomized trial","volume":"141","author":"Willems","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2022.01.016_bib54","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.295.2.165","article-title":"Comparison of \u03b2-blockers, amiodarone plus \u03b2-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC study: a randomized trial","volume":"295","author":"Connolly","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2022.01.016_bib55","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJM199906173402402","article-title":"Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group","volume":"340","author":"Pacifico","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2022.01.016_bib56","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1056\/NEJMoa065457","article-title":"Prophylactic catheter ablation for the prevention of defibrillator therapy","volume":"357","author":"Reddy","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2022.01.016_bib57","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10840-019-00535-w","article-title":"Pan-Asia United States PrEvention of Sudden Cardiac Death Catheter Ablation Trial (PAUSE-SCD): rationale and study design","volume":"57","author":"Chen","year":"2020","journal-title":"J\u00a0Interv Card Electrophysiol"},{"key":"10.1016\/j.cjca.2022.01.016_bib58","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1161\/01.CIR.0000149240.98971.A8","article-title":"Placebo-controlled, randomized clinical trial of azimilide for prevention of ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator","volume":"110","author":"Dorian","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2022.01.016_bib59","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.116.004422","volume":"10","author":"Kuck","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.cjca.2022.01.016_bib60","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/jama.2013.4598","article-title":"Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial","volume":"309","author":"Gasparini","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2022.01.016_bib61","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.hrthm.2015.01.017","article-title":"Low inappropriate shock rates in patients with single- and dual\/triple-chamber implantable cardioverter-defibrillators using a novel suite of detection algorithms: PainFree SST trial primary results","volume":"12","author":"Auricchio","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2022.01.016_bib62","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1093\/eurheartj\/ehp247","volume":"30","author":"Gasparini","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2022.01.016_bib63","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.hrthm.2014.02.009","article-title":"Impact of prolonged implantable cardioverter-defibrillator arrhythmia detection times on outcomes: a meta-analysis","volume":"11","author":"Scott","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2022.01.016_bib64","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/CIRCEP.113.001217","article-title":"Impact of programming strategies aimed at reducing nonessential implantable cardioverter defibrillator therapies on mortality: a systematic review and meta-analysis","volume":"7","author":"Tan","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X22000617?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X22000617?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:49:23Z","timestamp":1760107763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X22000617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S0828282X22000617"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2022.01.016","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ventricular Tachycardia Burden and Mortality: Association or Causality?","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2022.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc. on behalf of the Canadian Cardiovascular Society.","name":"copyright","label":"Copyright"}]}}